OliX Pharma Announces Expansion of Collaboration with Laboratoires Thea to Develop siRNA Therapeutics for Ophthalmic Diseases
OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, announced a collaboration with Théa Open Innovation, a sister company of Laboratoires Théa S.A.S ("Théa"),...
Amgen Announces Positive Topline Phase 2 Results For Investigational KRAS G12C Inhibitor Sotorasib In Lung Cancer
Amgen announced positive topline Phase 2 results from the CodeBreaK 100 clinical study, evaluating sotorasib (proposed INN for AMG 510) in 126 patients with...
CStone, Pfizer Enter into Strategic Collaboration to Address Oncological Needs in China
CStone Pharmaceuticals and Pfizer Investment Co. Ltd. and Pfizer Corporation Hong Kong Limited announced the formation of a strategic collaboration that encompasses a $200...
Lilly Announces Arrangement for Supply of Potential COVID-19 Antibody Therapy for Low- and Middle-Income Countries
Eli Lilly and Company and the Bill & Melinda Gates Foundation, as part of the COVID-19 Therapeutics Accelerator, have entered into an agreement to...
Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating VIR-7831 for the treatment of COVID-19
Vir Biotechnology, Inc. and GlaxoSmithKline plc announced the global expansion to Phase 3 of the COMET-ICE (COVID-19 Monoclonal antibody Efficacy Trial - Intent to...
CureVac initiates Phase 2a clinical trial of COVID-19 vaccine candidate
CureVac N.V., a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), announced that the first participant...
Eisai Enters Joint Development Agreement for COVID-19 Therapeutics
Eisai Co. has entered into a joint research agreement with four research organizations (KAN Research Institute, National Center for Global Health and Medicine, Nagasaki...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...